je.st
news
Bristol-Myers completes diabetes business sale
2014-02-03 17:46:40| Biotech - Topix.net
Drug developer Bristol-Myers Squibb Co. has received a $2.7 billion payment from Anglo-Swedish counterpart AstraZeneca PLC as part of the sale of its global diabetes business, a deal that could eventually be worth more than $4 billion.
Tags: business
sale
diabetes
completes
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||